Skip to content

The Effect of Subanesthetic Dose of Esketamine on Quality of Recovery in Children Undergoing Hip Surgery under ERAS Model

The Effect of Subanesthetic Dose of Esketamine on Quality of Recovery in Children Undergoing Hip Surgery under ERAS Model

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085375
Enrollment
Unknown
Registered
2024-06-06
Start date
2024-06-10
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip disease in children

Interventions

Experimental group:After entering the operation, 0.15 mg/kg esketamine was injected intravenously, and general anesthesia was induced 10 minutes later. Esketamine was pumped continuously at a rate of
Control group:The children were directly induced by general anesthesia. Esketamine is not used at all times

Sponsors

Beijing Jishuitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 7 Years

Inclusion criteria

Inclusion criteria: Age 3-7 years old; To undergo hip surgery under general anesthesia

Exclusion criteria

Exclusion criteria: Developmental retardation; Severe malnutrition; Craniocerebral injury; Cerebral palsy; Severe developmental malformations of the heart or other organs

Design outcomes

Primary

MeasureTime frame
Incidence of emergence delirium;

Secondary

MeasureTime frame
Preoperative anxiety score was assessed after entering the operating room;Intraoperative anesthetic dosage;Intraoperative vital signs;Adverse reaction;Pain score;Family satisfaction;

Countries

China

Contacts

Public ContactZhang Yi

Beijing Jishuitan Hospital

1535909633@qq.com+86 135 8182 1722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026